Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 174 Enz. Inhib. hit(s) with all data for entry = 6173
LigandPNGBDBM113428(US8633204, 127)
Affinity DataIC50:  0.480nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM50433038(CHEMBL2375957 | US8633204, 299)
Affinity DataIC50:  0.686nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113443(US8633204, 146)
Affinity DataIC50:  0.731nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113420(US8633204, 115)
Affinity DataIC50:  0.75nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113542(US8633204, 276)
Affinity DataIC50:  0.788nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113434(US8633204, 137)
Affinity DataIC50:  0.989nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113441(US8633204, 144)
Affinity DataIC50:  1.01nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113437(US8633204, 140)
Affinity DataIC50:  1.03nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113479(US8633204, 191)
Affinity DataIC50:  1.10nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113453(US8633204, 163)
Affinity DataIC50:  1.20nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113455(US8633204, 165)
Affinity DataIC50:  1.20nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113544(US8633204, 278)
Affinity DataIC50:  1.30nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113448(US8633204, 158)
Affinity DataIC50:  1.30nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113535(US8633204, 265)
Affinity DataIC50:  1.43nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113551(US8633204, 288)
Affinity DataIC50:  1.44nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113417(US8633204, 108)
Affinity DataIC50:  1.57nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM50433044(CHEMBL2375963 | US8633204, 304)
Affinity DataIC50:  1.58nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113543(US8633204, 277)
Affinity DataIC50:  1.59nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113461(US8633204, 171)
Affinity DataIC50:  1.60nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113469(US8633204, 180)
Affinity DataIC50:  1.60nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113495(US8633204, 217)
Affinity DataIC50:  1.60nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113526(US8633204, 254)
Affinity DataIC50:  1.70nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113432(US8633204, 135)
Affinity DataIC50:  1.77nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113541(US8633204, 274)
Affinity DataIC50:  1.80nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113527(US8633204, 255)
Affinity DataIC50:  2nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113489(US8633204, 207)
Affinity DataIC50:  2nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113571(US8633204, 318)
Affinity DataIC50:  2.14nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113550(US8633204, 287)
Affinity DataIC50:  2.20nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113536(US8633204, 266)
Affinity DataIC50:  2.20nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113540(US8633204, 273)
Affinity DataIC50:  2.30nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113490(US8633204, 210)
Affinity DataIC50:  2.30nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113467(US8633204, 177)
Affinity DataIC50:  2.40nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113557(US8633204, 294)
Affinity DataIC50:  2.60nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113477(US8633204, 189)
Affinity DataIC50:  2.70nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113499(US8633204, 221)
Affinity DataIC50:  2.80nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113545(US8633204, 279)
Affinity DataIC50:  2.90nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM50387590(CHEMBL2057725 | US8633204, 111)
Affinity DataIC50:  2.96nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113433(US8633204, 136)
Affinity DataIC50:  3.08nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113528(US8633204, 256)
Affinity DataIC50:  3.10nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113568(US8633204, 315)
Affinity DataIC50:  3.11nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM50433043(CHEMBL2375961 | US8633204, 307)
Affinity DataIC50:  3.62nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113485(US8633204, 201)
Affinity DataIC50:  3.70nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM50433045(CHEMBL2375964 | US8633204, 303)
Affinity DataIC50:  3.87nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113546(US8633204, 280)
Affinity DataIC50:  3.90nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113532(US8633204, 260)
Affinity DataIC50:  3.90nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113533(US8633204, 261)
Affinity DataIC50:  4nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM50433037(CHEMBL2375956 | US8633204, 311)
Affinity DataIC50:  4.11nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113465(US8633204, 175)
Affinity DataIC50:  4.30nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM113539(US8633204, 272)
Affinity DataIC50:  4.40nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


LigandPNGBDBM50387582(CHEMBL2057736 | US8633204, 196)
Affinity DataIC50:  4.5nMpH: 7.4 T: 25°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent


Displayed 1 to 50 (of 174 total ) | Next | Last >>
Jump to: